Home » Newsletters » BioWorld Science

BioWorld Science

May 2, 2005

View Archived Issues

DA-8159 as a treatment for diabetic erectile dysfunction

CC-4047's mechanism of action remains unclear

NexBio presents Fludase, a novel antiinfluenza recombinant fusion protein / News in Context

Two liposomal lurtotecan regimens induce antitumor effects in relapsed ovarian cancer

CEP-8983 chemosensitizes resistant cells and xenografts

BTS-2 inhibitory activity depends on redox state of tNOX

APF-530 enters phase II for CINV in cancer patients

ISTA seeks green light for phase III trial of combination ophthalmic product

ZLB Behring to study C1-INH concentrate for hereditary angioedema

Inspire reports ophthalmic programs update

Mitsubishi Chemical and Mitsubishi Pharma to form joint holding company

Phase I cancer study of CYT-997 set to begin in May

Prism to market Penwest's PW-2101 in U.S., Canada

Vical's bivalent CMV vaccine set for phase II

ISIS-369645 enters development for asthma

New treatments for cancer covered in recent patents

AS-1410 selected for phase I evaluation against cancer

Complete tumor regression in mice treated with huC242-DM4

First, highly selective 5-HT1D antagonist reported

Novel antihypertensive agents discovered at Bristol-Myers Squibb

Santarus reports new formulations of omeprazole for treating acid-induced gastrointestinal disorders

New antidiabetic agents from Ligand and Takeda

Phase I data confirm MVA-3000 vaccine is safe and immunogenic in healthy volunteers

Evidence suggests a link between sleep disorders and metabolic syndrome in mice

UNBS-1450 demonstrates in vitro and in vivo anticancer activity

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...